Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Vascularized Composite Allotransplantation (VCA) for Devastating Penile and Concomitant Genital Trauma

NCT03240822 is registered in ClinicalTrials.gov with Wake Forest University Health Sciences as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT03240822 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Vascularized Composite Allotransplantation (VCA) for Devastating Penile and Concomitant Genital Trauma
Lead sponsor
Wake Forest University Health Sciences
Phase
Phase 1
Overall status
Withdrawn
Start date
January 31, 2017
Completion date
December 31, 2025
Enrollment
0 (actual)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

amputation, genital diseases, male, urologic injuries